Neurava
Baltimore, US · Founded 2022 · Delaware corporation · 3 known investors
Neurava develops AI-powered wearable devices designed to monitor seizures and cardiorespiratory dysfunction in people with epilepsy, aiming to mitigate the risk of SUDEP (Sudden Unexpected Nocturnal Death in Epilepsy). The company combines neuromodulation expertise with machine learning to create a novel medical device platform for epilepsy management.
Founders & leadership
Investors · 3
Reported raises · per SEC filings
Form D private placements▶$1.6MraisedOct 2025 · 2 investors · Other TechnologyRule 506(b)
▶$1.6MraisedOct 2025 · 2 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Mona ChadhaDirector
- Vivek GaneshExecutive Officer, Director, Promoter
- Daniel MooreDirector
- Jay ShahExecutive Officer, Director, Promoter
- John KayDirector
- Offering amount
- $7M
- Amount sold
- $1.6M
- First sale
- Oct 2025
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$1.9MraisedAug 2023 · 16 investors · Other TechnologyRule 506(b)
▶$1.9MraisedAug 2023 · 16 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Jay ShahExecutive Officer, Director, Promoter
- Mona ChadhaDirector
- Kristin EilenbergDirector
- Vivek GaneshDirector
- Offering amount
- $2.5M
- Amount sold
- $1.9M
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$656.3KraisedSep 2021 · 9 investors · Other TechnologyRule 506(b)
▶$656.3KraisedSep 2021 · 9 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Jay ShahExecutive Officer, Director, Promoter
- Vivek GaneshDirector
- Offering amount
- $750K
- Amount sold
- $656.3K
- First sale
- Aug 2021
- Incorporated
- Limited Liability Company, Indiana, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Neurava Raises $2.26M in Seed Fundingfinsmes.com · 2024
- Neurava raises over $2M to advance life-saving epilepsy monitoring deviceprnewswire.com · 2024


